{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T18:13:17Z","timestamp":1789495997659,"version":"build-2803163510"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010029","name":"Taishan Scholar Foundation of Shandong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010029","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Gerontology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.exger.2025.112935","type":"journal-article","created":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T14:39:14Z","timestamp":1760798354000},"page":"112935","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["SGLT2 inhibitor, bone metabolism biomarkers, and osteoporosis risk: A Mendelian randomization study"],"prefix":"10.1016","volume":"211","author":[{"given":"Xin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yibing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhichao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exger.2025.112935_bb0005","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41581-022-00665-x","article-title":"Regulation of FGF23 production and phosphate metabolism by bone-kidney interactions","volume":"19","author":"Agoro","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.exger.2025.112935_bb0010","article-title":"SGLT2 inhibitor treatment is not associated with an increased risk of osteoporotic fractures when compared to GLP-1 receptor agonists: a nationwide cohort study","volume":"13","author":"Al-Mashhadi","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.exger.2025.112935_bb0015","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41574-021-00477-2","article-title":"Hormonal regulation of biomineralization","volume":"17","author":"Arnold","year":"2021","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.exger.2025.112935_bb0020","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1161\/STROKEAHA.122.040598","article-title":"Anti-epileptic drug target perturbation and intracranial aneurysm risk: Mendelian randomization and colocalization study","volume":"54","author":"Bakker","year":"2023","journal-title":"Stroke"},{"key":"10.1016\/j.exger.2025.112935_bb0025","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1080\/00273171.2010.498292","article-title":"Assessing mediational models: testing and interval estimation for indirect effects","volume":"45","author":"Biesanz","year":"2010","journal-title":"Multivar. Behav. Res."},{"key":"10.1016\/j.exger.2025.112935_bb0030","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet. Epidemiol."},{"key":"10.1016\/j.exger.2025.112935_bb0035","doi-asserted-by":"crossref","DOI":"10.1093\/ije\/dyy101","article-title":"Improving the visualization, interpretation and analysis of two-sample summary data Mendelian randomization via the radial plot and radial regression","volume":"47","author":"Bowden","year":"2018","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.exger.2025.112935_bb0040","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1002\/jbmr.4880","article-title":"Evaluation of the effect of sodium-glucose cotransporter 2 inhibition on fracture risk: evidence from Mendelian randomization and genetic association study","volume":"38","author":"Dai","year":"2023","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.exger.2025.112935_bb0045","series-title":"022The MRC IEU OpenGWAS Data Infrastructure","author":"Elsworth","year":"2020"},{"key":"10.1016\/j.exger.2025.112935_bb0050","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1126\/science.aaz1776","article-title":"20 The GTEx Consortium atlas of genetic regulatory effects across human tissues","volume":"369","author":"GTEx Consortium","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.exger.2025.112935_bb0055","doi-asserted-by":"crossref","first-page":"446","DOI":"10.2967\/jnumed.120.256180","article-title":"Bone mineral density: clinical relevance and quantitative assessment","volume":"62","author":"Haseltine","year":"2021","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.exger.2025.112935_bb0060","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.1093\/bioinformatics\/btz469","article-title":"PhenoScanner V2: an expanded tool for searching human genotype-phenotype associations","volume":"35","author":"Kamat","year":"2019","journal-title":"Bioinformatics"},{"key":"10.1016\/j.exger.2025.112935_bb0065","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/MNH.0000000000000887","article-title":"Safety of SGLT2i with regard to bone and mineral metabolism in patients with CKD","volume":"32","author":"Kaze","year":"2023","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.exger.2025.112935_bb0070","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1093\/eurheartj\/ehad736","article-title":"Mendelian randomization for cardiovascular diseases: principles and applications","volume":"44","author":"Larsson","year":"2023","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.exger.2025.112935_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2024.111712","article-title":"Association of sodium-glucose cotransporter 2 inhibitor use with risk of osteoporotic fracture among older women: a nationwide, population-based cohort study","volume":"213","author":"Lee","year":"2024","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.exger.2025.112935_bb0080","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2337\/dc18-1965","article-title":"Frailty and risk of fractures in patients with type 2 diabetes","volume":"42","author":"Li","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.exger.2025.112935_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1009922","article-title":"Combining the strengths of inverse-variance weighting and Egger regression in Mendelian randomization using a mixture of regressions model","volume":"17","author":"Lin","year":"2021","journal-title":"PLoS Genet."},{"key":"10.1016\/j.exger.2025.112935_bb0090","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1210\/clinem\/dgab274","article-title":"Clinical adverse events associated with sodium-glucose cotransporter 2 inhibitors: a meta-analysis involving 10 randomized clinical trials and 71 553 individuals","volume":"106","author":"Lin","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.exger.2025.112935_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1010166","article-title":"A practical problem with Egger regression in Mendelian randomization","volume":"18","author":"Lin","year":"2022","journal-title":"PLoS Genet."},{"key":"10.1016\/j.exger.2025.112935_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113679","article-title":"Unfavorable effects of sodium-glucose cotransporter 2 (SGLT2) inhibitors on the skeletal system of nondiabetic rats","volume":"155","author":"Londzin","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.exger.2025.112935_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.117912","article-title":"Effects of sodium-glucose cotransporter 2 (SGLT2) inhibitors, dapagliflozin and canagliflozin, on the musculoskeletal system in an experimental model of diabetes induced by high-fat diet and streptozotocin in rats","volume":"184","author":"Londzin","year":"2025","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.exger.2025.112935_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2023.110576","article-title":"Fracture risks associated with sodium-glucose cotransporter-2 inhibitors in type 2 diabetes patients across eGFR and albuminuria categories: a population-based study in Hong Kong","volume":"197","author":"Lui","year":"2023","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.exger.2025.112935_bb0115","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41588-022-01058-3","article-title":"Multi-ancestry genetic study of type 2 diabetes highlights the power of diverse populations for discovery and translation","volume":"54","author":"Mahajan","year":"2022","journal-title":"Nat. Genet."},{"key":"10.1016\/j.exger.2025.112935_bb0120","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1245642","article-title":"Sodium-glucose cotransporter-2 (SGLT2) inhibitors and the reporting of falls and fractures: an european pharmacovigilance analysis","volume":"14","author":"Mascolo","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.exger.2025.112935_bb0125","doi-asserted-by":"crossref","DOI":"10.1172\/JCI180073","article-title":"Metabolic benefits afforded by estradiol and testosterone in both sexes: clinical considerations","volume":"134","author":"Mauvais-Jarvis","year":"2024","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.exger.2025.112935_bb0130","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/s41588-021-00870-7","article-title":"03 computationally efficient whole-genome regression for quantitative and binary traits","volume":"53","author":"Mbatchou","year":"2021","journal-title":"Nat. Genet."},{"key":"10.1016\/j.exger.2025.112935_bb0135","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s40264-020-01010-6","article-title":"Potential safety issues with use of sodium-glucose cotransporter 2 inhibitors, particularly in people with type 2 diabetes and chronic kidney disease","volume":"43","author":"Milder","year":"2020","journal-title":"Drug Saf."},{"key":"10.1016\/j.exger.2025.112935_bb0140","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.3390\/ijms26031094","article-title":"Type 2 diabetes mellitus: new pathogenetic mechanisms, treatment and the most important complications","volume":"26","author":"M\u0142ynarska","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.exger.2025.112935_bb0145","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13041056","article-title":"The role of sodium-glucose cotransporter-2 inhibitors in the treatment of polycystic ovary syndrome: a review","volume":"13","author":"Porth","year":"2024","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.exger.2025.112935_bb0150","first-page":"812","article-title":"Canagliflozin-induced adaptive metabolism in bone","volume":"74","author":"Poudel","year":"2025","journal-title":"Diabetes"},{"key":"10.1016\/j.exger.2025.112935_bb0155","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1038\/s41588-021-00931-x","article-title":"06 a cross-population atlas of genetic associations for 220 human phenotypes","volume":"53","author":"Sakaue","year":"2021","journal-title":"Nat. Genet."},{"key":"10.1016\/j.exger.2025.112935_bb0160","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41574-020-0392-2","article-title":"10 sodium-glucose cotransporter type 2 inhibitors for the treatment of type 2 diabetes mellitus","volume":"16","author":"Scheen","year":"2020","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.exger.2025.112935_bb0165","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1038\/s41467-020-16969-0","article-title":"Genetic drug target validation using Mendelian randomisation","volume":"11","author":"Schmidt","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.exger.2025.112935_bb0170","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.830401","article-title":"A meta-analysis of the effect of sodium glucose cotransporter-2 inhibitors on metabolic parameters in patients with polycystic ovary syndrome","volume":"13","author":"Sinha","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.exger.2025.112935_bb0175","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1001\/jama.2021.18236","article-title":"Strengthening the reporting of observational studies in epidemiology using Mendelian randomization: the STROBE-MR statement","volume":"326","author":"Skrivankova","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.exger.2025.112935_bb0180","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1038\/s41467-025-57912-5","article-title":"Leveraging pleiotropic clustering to address high proportion correlated horizontal pleiotropy in Mendelian randomization studies","volume":"16","author":"Tang","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.exger.2025.112935_bb0185","doi-asserted-by":"crossref","first-page":"5546","DOI":"10.1038\/s41598-025-89985-z","article-title":"The association between sex hormones and bone mineral density in US females","volume":"15","author":"Tian","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.exger.2025.112935_bb0190","doi-asserted-by":"crossref","first-page":"E178","DOI":"10.1503\/cmaj.240922","article-title":"Sodium-glucose cotransporter 2 (SGLT2) inhibitors and risk of chronic kidney disease-mineral and bone disorders in patients with type 2 diabetes mellitus and stage 1-3 chronic kidney disease","volume":"197","author":"Tsai","year":"2025","journal-title":"CMAJ"},{"key":"10.1016\/j.exger.2025.112935_bb0195","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.3390\/biomedicines12081830","article-title":"Exploring the role of hormones and cytokines in osteoporosis development","volume":"12","author":"Umur","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.exger.2025.112935_bb0200","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S2213-8587(24)00102-5","article-title":"Effect of SGLT2 inhibitors on heart failure outcomes and cardiovascular death across the cardiometabolic disease spectrum: a systematic review and meta-analysis","volume":"12","author":"Usman","year":"2024","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.exger.2025.112935_bb0205","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat. Genet."},{"key":"10.1016\/j.exger.2025.112935_bb0210","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/s41588-021-00913-z","article-title":"21 large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression","volume":"53","author":"V\u00f5sa","year":"2021","journal-title":"Nat. Genet."},{"key":"10.1016\/j.exger.2025.112935_bb0215","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1007\/s00198-023-06908-2","article-title":"14 effect of SGLT2 inhibitors on fractures, BMD, and bone metabolism markers in patients with type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"34","author":"Wang","year":"2023","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.exger.2025.112935_bb0220","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12902-024-01575-8","article-title":"Effects of sodium-glucose cotransporter 2 inhibitors on bone metabolism in patients with type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"24","author":"Wang","year":"2024","journal-title":"BMC Endocr. Disord."},{"key":"10.1016\/j.exger.2025.112935_bb0225","article-title":"Effect of drugs used in pharmacotherapy of type 2 diabetes on bone density and risk of bone fractures","volume":"60","author":"Wikarek","year":"2024","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.exger.2025.112935_bb0230","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41572-021-00289-8","article-title":"Non-union bone fractures","volume":"7","author":"Wildemann","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.exger.2025.112935_bb0235","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1052592","article-title":"A narrative review of diabetic bone disease: characteristics, pathogenesis, and treatment","volume":"13","author":"Wu","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.exger.2025.112935_bb0240","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.ajhg.2022.04.001","article-title":"Combining evidence from Mendelian randomization and colocalization: review and comparison of approaches","volume":"109","author":"Zuber","year":"2022","journal-title":"Am. J. Hum. Genet."}],"container-title":["Experimental Gerontology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0531556525002645?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0531556525002645?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T09:04:19Z","timestamp":1780304659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0531556525002645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":48,"alternative-id":["S0531556525002645"],"URL":"https:\/\/doi.org\/10.1016\/j.exger.2025.112935","relation":{},"ISSN":["0531-5565"],"issn-type":[{"value":"0531-5565","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SGLT2 inhibitor, bone metabolism biomarkers, and osteoporosis risk: A Mendelian randomization study","name":"articletitle","label":"Article Title"},{"value":"Experimental Gerontology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exger.2025.112935","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"112935"}}